Nurix Therapeutics Correlations

NRIX Stock

USD 20.02 0.37 1.88%

The current 90-days correlation between Nurix Therapeutics and Foghorn Therapeutics is 0.5 (i.e., Very weak diversification). The correlation of Nurix Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Nurix Therapeutics Correlation With Market

Modest diversification

The correlation between Nurix Therapeutics and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Nurix Stock please use our How to Invest in Nurix Therapeutics guide.

Moving together with Nurix Stock

0.79	JNJ	Johnson Johnson	Pair Corr
0.77	INZY	Inozyme Pharma	Pair Corr
0.64	KRYS	Krystal Biotech	Pair Corr
0.74	MREO	Mereo BioPharma Group	Pair Corr
0.84	NKTX	Nkarta Inc	Pair Corr
0.92	PDSB	PDS Biotechnology Corp	Pair Corr
0.93	ABOS	Acumen Pharmaceuticals	Pair Corr
0.81	ADAP	Adaptimmune Therapeutics	Pair Corr
0.91	AFMD	Affimed NV	Pair Corr
0.64	AGIO	Agios Pharm	Pair Corr
0.9	AMGN	Amgen Inc Earnings Call This Week	Pair Corr
0.84	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.83	APTO	Aptose Biosciences	Pair Corr
0.74	STOK	Stoke Therapeutics	Pair Corr
0.93	BDTX	Black Diamond Therap	Pair Corr
0.71	TERN	Terns Pharmaceuticals Buyout Trend	Pair Corr
0.78	CRVS	Corvus Pharmaceuticals	Pair Corr
0.92	DAWN	Day One Biopharmaceu	Pair Corr
0.83	ACET	Adicet Bio	Pair Corr
0.85	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.63	WF	Woori Financial Group Earnings Call This Week	Pair Corr

Moving against Nurix Stock

0.66	MLAB	Mesa Laboratories Earnings Call This Week	Pair Corr
0.38	BMY	Bristol Myers Squibb Earnings Call This Week	Pair Corr
0.44	PTCT	PTC Therapeutics	Pair Corr
0.81	FNMFO	Federal National Mortgage	Pair Corr
0.6	MNPR	Monopar Therapeutics	Pair Corr
0.55	AVAL	Grupo Aval	Pair Corr
0.44	ITCL	Banco Ita Chile	Pair Corr
0.41	TGNA	Tegna Inc	Pair Corr
0.38	CIB	Bancolombia SA ADR	Pair Corr

Related Correlations Analysis

	FHTX	STTK	GLUE	KYMR	CCCC	ARVN	ELYM	PRLD	RLAY	STOK
FHTX		0.12	0.77	0.85	0.8	0.93	0.91	0.06	0.75	0.78	FHTX
STTK	0.12		0.1	0.21	0.35	0.26	0.32	0.46	0.38	0.3	STTK
GLUE	0.77	0.1		0.65	0.51	0.78	0.67	-0.17	0.36	0.78	GLUE
KYMR	0.85	0.21	0.65		0.83	0.88	0.85	0.22	0.78	0.72	KYMR
CCCC	0.8	0.35	0.51	0.83		0.81	0.94	0.42	0.92	0.67	CCCC
ARVN	0.93	0.26	0.78	0.88	0.81		0.9	0.17	0.74	0.76	ARVN
ELYM	0.91	0.32	0.67	0.85	0.94	0.9		0.26	0.87	0.8	ELYM
PRLD	0.06	0.46	-0.17	0.22	0.42	0.17	0.26		0.44	0.02	PRLD
RLAY	0.75	0.38	0.36	0.78	0.92	0.74	0.87	0.44		0.58	RLAY
STOK	0.78	0.3	0.78	0.72	0.67	0.76	0.8	0.02	0.58		STOK
	FHTX	STTK	GLUE	KYMR	CCCC	ARVN	ELYM	PRLD	RLAY	STOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ELYM	+ 0.94	CCCC
ARVN	+ 0.93	FHTX
RLAY	+ 0.92	CCCC
ELYM	+ 0.91	FHTX
ELYM	+ 0.9	ARVN
ARVN	+ 0.88	KYMR

High negative correlations

PRLD

- 0.17

GLUE

Risk-Adjusted Indicators

There is a big difference between Nurix Stock performing well and Nurix Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nurix Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FHTX	3.24	(0.93)	0.00	(0.46)	0.00	0.00	5.05	(8.30)	20.44
STTK	4.25	0.12	0.00	(0.37)	4.85	(4.94)	10.74	(9.01)	22.78
GLUE	5.58	0.96	0.17	7.48	4.45	(7.48)	10.21	(8.46)	103.72
KYMR	2.87	(0.35)	0.00	(0.16)	0.00	0.00	5.88	(7.08)	16.08
CCCC	4.02	(0.75)	0.00	(0.39)	0.00	0.00	8.59	(7.99)	24.60
ARVN	3.21	(0.60)	0.00	(0.84)	0.00	0.00	4.96	(6.68)	23.09
ELYM	3.62	(1.23)	0.00	(0.67)	0.00	0.00	6.00	(9.35)	22.16
PRLD	5.07	(0.26)	0.00	(0.08)	0.00	0.00	12.50	(9.09)	55.77
RLAY	3.49	(0.43)	0.00	(0.57)	0.00	0.00	7.42	(7.87)	24.83
STOK	2.93	(0.10)	0.00	(0.12)	0.00	0.00	5.79	(7.10)	27.59

Nurix Therapeutics Corporate Management

Stefani Wolff	COO Devel	Profile
Christine JD	Secretary Officer	Profile
John Kuriyan	Founder Board	Profile
JD Esq	VP Counsel	Profile
Cristiana Guiducci	Senior Research	Profile
Pasit Phiasivongsa	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC